Asset Dedication, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Asset Dedication, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$9
-18.2%
377
+7.7%
0.00%0.0%
Q2 2023$11
+10.0%
350
-1.4%
0.00%0.0%
Q1 2023$10
-23.1%
355
+33.0%
0.00%0.0%
Q4 2022$13
-99.9%
2670.0%0.00%0.0%
Q3 2022$13,000
-31.6%
267
-15.0%
0.00%
-66.7%
Q2 2022$19,000
-72.5%
314
-65.6%
0.00%
-62.5%
Q1 2022$69,000
-9.2%
9120.0%0.01%
-11.1%
Q4 2021$76,000
+4.1%
912
+1.1%
0.01%
-10.0%
Q3 2021$73,000
-34.2%
902
-34.3%
0.01%
-41.2%
Q2 2021$111,000
+73.4%
1,373
+81.1%
0.02%
+21.4%
Q1 2021$64,000
-41.8%
758
-44.8%
0.01%
-36.4%
Q4 2020$110,000
-0.9%
1,3730.0%0.02%
-8.3%
Q3 2020$111,000
-2.6%
1,373
+3.8%
0.02%
-22.6%
Q2 2020$114,000
+6.5%
1,3230.0%0.03%
-3.1%
Q1 2020$107,000
+24.4%
1,323
+28.7%
0.03%
+33.3%
Q4 2019$86,000
+19.4%
1,028
+24.2%
0.02%0.0%
Q3 2019$72,000
+56.5%
828
+46.5%
0.02%
+60.0%
Q2 2019$46,0000.0%5650.0%0.02%
-6.2%
Q1 2019$46,000
+17.9%
565
-5.2%
0.02%0.0%
Q4 2018$39,000
-11.4%
596
+5.5%
0.02%
-5.9%
Q3 2018$44,000
+4.8%
5650.0%0.02%
+21.4%
Q2 2018$42,000
+13.5%
5650.0%0.01%
-22.2%
Q1 2018$37,0000.0%5650.0%0.02%
+20.0%
Q4 2017$37,000
+5.7%
5650.0%0.02%
-11.8%
Q3 2017$35,000
+2.9%
5650.0%0.02%0.0%
Q2 2017$34,000
+17.2%
5650.0%0.02%
+6.2%
Q1 2017$29,000
+16.0%
5650.0%0.02%
+6.7%
Q4 2016$25,000565
+11200.0%
0.02%
Q1 2016$050.00%
Other shareholders
BAXTER INTL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders